AURORA PRIORITIZES HIGH-MARGIN MED, WON’T BET ON BEVS

https://www.flickr.com/people/71132408@N00

Aurora reported $75M Q3 revenue, representing a 365% increase year over year. The company reported a net loss of $158.3M, compared with $19.2M year over year. REC sales grew 37% over the last quarter and MED sales grew 12%.MJ Biz Daily, NewsWire

• The company is 

  Log in or become a WeedWeek Member to read this article.